  Myeloid sarcoma<disease> is a rare presentation of acute leukemia<disease> as a solid tumor at various extramedullary sites. It may present concurrently , before or after the onset of systemic bone<disease> marrow leukemia<disease>. Unusual clinical localization may lead to misdiagnosis , or delayed diagnosis and treatment. We describe the first case , to our knowledge , of de novo myeloid sarcoma<disease> of the breast confirmed as acute promyelocytic leukemia<disease>. Immunohistochemical analysis , flow cytometry , fluorescent in situ hybridization analysis and molecular analysis using RQ-PCR of tissue samples should be routine in determining the correct diagnosis in this setting.